Synova Life Sciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

Synova Life Sciences General Information

Description

Developer of a fat processing device designed to harvest autologous stem cells for treatment. The company's system processes adipose-derived tissue to isolate stem cells while preserving their regenerative properties, enabling physicians to utilize patient-derived cells for therapeutic applications in managing degenerative conditions and promoting tissue repair.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 686 South Fair Oaks Avenue
  • Pasadena, CA 91105
  • United States
+1 (833)
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 686 South Fair Oaks Avenue
  • Pasadena, CA 91105
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synova Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 01-Feb-2024 Completed Generating Revenue
10. Accelerator/Incubator Completed Startup
9. Later Stage VC 01-Jun-2023 Completed Startup
8. Accelerator/Incubator 15-Jul-2022 Completed Startup
7. Secondary Transaction - Private 24-Jan-2022 Completed Startup
6. Accelerator/Incubator 01-Jan-2022 Completed Startup
5. Seed Round 31-Aug-2021 Completed Startup
4. Seed Round 15-Jul-2020 Completed Startup
3. Accelerator/Incubator $150K Completed Startup
2. Accelerator/Incubator 18-Mar-2019 $150K $150K Completed Startup
To view Synova Life Sciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Synova Life Sciences Patents

Synova Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2884348-T3 Cell separation, dissociation and / or disaggregation using mechanical impacts Active 17-Mar-2016
EP-3872164-B1 Isolating stem cells from adipose tissue Active 17-Mar-2016
EP-3872164-C0 Isolating stem cells from adipose tissue Active 17-Mar-2016
ES-2964374-T3 Isolation of stem cells from adipose tissue Active 17-Mar-2016
EP-3430122-B1 Separation, dissociation and/or disaggregation of cells using mechanical impacts Active 17-Mar-2016 C12N5/0667
To view Synova Life Sciences’s complete patent history, request access »

Synova Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synova Life Sciences Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
McNamara Investments Family Office Minority
Unpopular Ventures Venture Capital Minority
Seraph Group Venture Capital Minority
Titan Angels Angel Group Minority
Creative Destruction Lab Accelerator/Incubator
You’re viewing 5 of 14 investors. Get the full list »

Synova Life Sciences FAQs

  • When was Synova Life Sciences founded?

    Synova Life Sciences was founded in 2013.

  • Where is Synova Life Sciences headquartered?

    Synova Life Sciences is headquartered in Pasadena, CA.

  • What is the size of Synova Life Sciences?

    Synova Life Sciences has 6 total employees.

  • What industry is Synova Life Sciences in?

    Synova Life Sciences’s primary industry is Other Devices and Supplies.

  • Is Synova Life Sciences a private or public company?

    Synova Life Sciences is a Private company.

  • What is Synova Life Sciences’s current revenue?

    The current revenue for Synova Life Sciences is .

  • How much funding has Synova Life Sciences raised over time?

    Synova Life Sciences has raised $2.48M.

  • Who are Synova Life Sciences’s investors?

    McNamara Investments, Unpopular Ventures, Seraph Group, Titan Angels, and Creative Destruction Lab are 5 of 14 investors who have invested in Synova Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process